Pfizer (PFE) Stock Price Target 2026

The average analyst price target for Pfizer is $30.55, 4.9% above the current price. Of 19 analysts, 7 rate it Buy, 10 Hold and 2 Sell. Targets range from $25 to $45. The latest change came on Nov 5, 2026, when Guggenheim raised its price target on Pfizer from $31 to $33 and kept a Buy rating.

The Average Analyst Price Target for Pfizer is $30.55.

Price Target Range — 13 Quarters

Analyst Consensus — 19 Analysts

7Buy

10Hold

2Sell

Consensus RatingNeutral# Analysts19Avg. Consensus PT$30.55Upside to Avg. PT+4.9%

Rating Trend — Last 9 Months

Latest Upgrades and Downgrades for Pfizer Stock

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Nov 5, 2026	Guggenheim	Vamil Divan	PT Raise	Buy	$31→$33
Nov 4, 2026	UBS	Michael Yee	PT Raise	Neutral	$27→$30
Nov 4, 2026	Scotiabank	Louise Chen	PT Raise	Sector Outperform	$33→$35
Nov 4, 2026	Citigroup	Geoff Meacham	PT Raise	Neutral	$27→$30
Nov 4, 2026	RBC Capital	Trung Huynh	PT Raise	Sector Perform	$25→$28
Oct 9, 2026	JP Morgan	Chris Schott	PT Raise	Neutral	$28→$30
Oct 8, 2026	Cantor Fitzgerald	Carter Gould	PT Raise	Neutral	$27→$28
Oct 6, 2026	Scotiabank	Louise Chen	PT Raise	Sector Outperform	$30→$33
Sep 10, 2026	HSBC	Rajesh Kumar	PT Raise	Hold	$28→$30
Aug 7, 2026	Guggenheim	Vamil Divan	PT Cut	Buy	$35→$31
Jul 13, 2026	BMO Capital	Evan David Seigerman	PT Cut	Outperform	$34→$30
Jul 13, 2026	Guggenheim	Vamil Divan	PT Cut	Buy	$36→$35
Jul 10, 2026	B of A Securities	Jason Gerberry	PT Cut	Neutral	$27→$26
Jul 8, 2026	JP Morgan	Chris Schott	PT Cut	Neutral	$30→$28
Jul 6, 2026	Cantor Fitzgerald	Carter Gould	Maintained	Neutral	$27
Jul 6, 2026	HSBC	Rajesh Kumar	Downgrade	Buy→Hold	$32→$28
Jun 10, 2026	RBC Capital	Trung Huynh	Upgrade	Underperform→Sector Perform	$25
Apr 29, 2026	Citigroup	Geoff Meacham	PT Raise	Neutral	$26→$27
Apr 20, 2026	RBC Capital	Trung Huynh	Maintained	Underperform	$25
Apr 16, 2026	CICC	Jin Zhang	Initiate	Outperform	$33